Skip to main content

Very Rare Malignant Tumors Program News

Your child will be cared for by world leaders in rare childhood cancers. We provide medical care, emotional counseling and much more. We make sure your child and every member of your family get the highest level of support.

Existing patients or family members
New patients, referrals and second opinions

In the Journals: Nirsevimab

Jan 18, 2024

Find out about the results of a prospective, placebo-controlled trial in 8,058 healthy infants that served as the basis for licensure of nirsevimab.

Jump back to top